KEGG   DRUG: Lipegfilgrastim
Entry
D10242                      Drug                                   
Name
Lipegfilgrastim (USAN);
Lonquex (TN)
Formula
C866H1372N226O258So. (C2H4O)n
Sequence
MTPLGPASSL PQSFLLKCLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA
PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ
QMEELGMAPA LQPTQGAMPA FASAFQRRAG GVLVASHLQS FLEVSYRVLR HLAQP
  Type
Peptide
Class
Immunological agent
 DG01753  Colony stimulating factor
  DG01781  Granulocyte colony stimulating factor (G-CSF)
Remark
ATC code: L03AA14
Efficacy
Antineutropenic, Hematopoietic stimulant, Granulocyte colony stimulating factor (G-CSF)
Comment
glycosylated and pegylated G-CSF [HSA:1440] [KO:K05423]
Target
CSF3R (GCSFR, CD114) [HSA:1441] [KO:K05061]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04151  PI3K-Akt signaling pathway
hsa04630  JAK-STAT signaling pathway
hsa04640  Hematopoietic cell lineage
hsa05200  Pathways in cancer
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L03 IMMUNOSTIMULANTS
   L03A IMMUNOSTIMULANTS
    L03AA Colony stimulating factors
     L03AA14 Lipegfilgrastim
      D10242  Lipegfilgrastim (USAN)
Drug groups [BR:br08330]
 Immunological agent
  DG01753  Colony stimulating factor
   DG01781  Granulocyte colony stimulating factor (G-CSF)
    D10242  Lipegfilgrastim
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   CSF and other factor receptors
    CSF3R (GCSFR, CD114)
     D10242  Lipegfilgrastim (USAN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10242
Other DBs
CAS: 1117844-87-7
PubChem: 163312273
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system